Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library.
about
Chemical strategies for the covalent modification of filamentous phageVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmStructural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumabRecombinant antibodies for cancer diagnosis and therapy.Phage display selection for cell-specific ligands: development of a screening procedure suitable for small tumor specimens.A novel assay for monitoring internalization of nanocarrier coupled antibodies.Obligate multivalent recognition of cell surface tomoregulin following selection from a multivalent phage antibody library.Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo.Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigensIdentifying blood-brain-barrier selective single-chain antibody fragments.Generation of recombinant guinea pig antibody fragments to the human GABAC receptor.Beyond natural antibodies: the power of in vitro display technologies.Discovery of internalizing antibodies to tumor antigens from phage libraries.Selection and characterization of cell binding and internalizing phage antibodies.Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches.Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies.Streamlining hit discovery and optimization with a yoctoliter scale DNA reactor.Selection strategies for anticancer antibody discovery: searching off the beaten path.Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approachEpidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cellsTargeting membrane proteins for antibody discovery using phage display.Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in MiceState of the art in tumor antigen and biomarker discovery.Targeted endothelial nanomedicine for common acute pathological conditions.Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3.The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).Ligandomics: a paradigm shift in biological drug discovery.Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins
P2860
Q26992196-7AE8DC3D-42BE-444C-9ACF-6D2FC02C3F7BQ27026630-09F35C0C-E69E-4B2C-9B2C-891628D6627BQ30274619-B4453AA5-87C4-4618-910A-08C8A22DFBE7Q30771917-B94869F9-A40C-4313-8A0C-BC6AC47874FAQ33214333-15CB2AB3-9CCA-4420-BF87-EBD2F28DA11EQ33259109-A10E9CBC-E9E2-4CE1-9E07-2A21B1D58F73Q33263079-96FD783B-AAAD-40DE-9CAB-03C95C5040A2Q33284494-F0FDC173-EE3B-47EF-B27A-F17D6A2368E2Q33289414-07CE0EF0-7F17-434B-8C5D-6FF654F38DF0Q33480823-3FC0925C-4CB3-4342-A898-E1FB435211B0Q33695432-F951A3F8-8A0E-4A37-8D9B-BAC67788A376Q33816474-9733E863-A406-42FF-9F9C-CF5A80200FB9Q33833260-9B950BC5-7208-4611-ADC3-A4EDEBB23D4DQ33841864-43A59D9C-D06F-4028-87F9-A62F6EAD5796Q34114794-FBC988D7-78FB-4B78-B0F5-00A6D773205FQ34280931-9BCC78B2-04C8-4186-A8D9-3DFD9402B6FDQ34330122-E555F1ED-7E56-41C5-A9B8-35B42AE6D200Q34404779-ED361503-8AB1-4E1A-8C8A-6DF2B4A9834DQ34616688-F557E3CD-7A7E-42C9-9F10-2B3229ECDB08Q35589427-766E2367-56D1-4215-8C29-BE8E714A3FDCQ35718010-12337DF1-6B2D-44DA-A3C2-A8F5EA4742C8Q35764163-C95B747F-ED05-4BC4-83D6-5D2ABAF924EEQ35973340-57DB9706-8794-4CBC-A8CD-711388B63DEBQ36020577-94408BA8-7E8B-4ADA-B120-8DCA9C0262EEQ36028047-5D339A78-29D9-4A59-A653-BF71FBBB8136Q37132800-0478054E-541E-43A8-8C09-2645DC72CC4AQ38598987-9FBA8F42-775E-4786-B3E5-F6C1ACFF08CCQ40741125-A63DA886-D32D-4671-8CD4-C258493985CAQ47675852-2F71C2E2-A4FD-4742-B124-693EF53ED596Q50078681-DBEBA75A-18A4-4110-AD4C-645E38008323Q57912158-3377E2A9-D320-4095-87E6-6F57D8C04E7A
P2860
Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Selection of cell binding and ...... from a phage display library.
@ast
Selection of cell binding and ...... from a phage display library.
@en
type
label
Selection of cell binding and ...... from a phage display library.
@ast
Selection of cell binding and ...... from a phage display library.
@en
prefLabel
Selection of cell binding and ...... from a phage display library.
@ast
Selection of cell binding and ...... from a phage display library.
@en
P2093
P1476
Selection of cell binding and ...... from a phage display library.
@en
P2093
P356
10.1016/S0022-1759(00)00340-9
P577
2001-02-01T00:00:00Z